Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of CLSD will decline by -100.00% over the next 2 Weeks and hit $0.00 by Monday, March 23, 2026. In that time frame, CLSD's share price is expected to range between $0.00 and $0.90.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Mar 23, 2026 | 0.00 | 0.00 | 0.30 |
| Mar 20, 2026 | 0.00 | 0.00 | 0.06 |
| Mar 19, 2026 | 0.00 | 0.00 | 0.35 |
| Mar 18, 2026 | 0.00 | 0.00 | 0.16 |
| Mar 17, 2026 | 0.00 | 0.00 | 0.01 |
| Mar 16, 2026 | 0.00 | 0.00 | 0.48 |
| Mar 13, 2026 | 0.00 | 0.00 | 0.34 |
| Mar 12, 2026 | 0.00 | 0.00 | 0.57 |
| Mar 11, 2026 | 0.00 | 0.00 | 0.37 |
| Mar 10, 2026 | 0.00 | 0.00 | 0.22 |
CLSD shares remained flat 0 in Thursday, March 12, 2026's trading session, starting and closing at a previous close of $0.41 to move at $0.41. The stock demonstrated notable intraday movement (see CLSD's key stats for a full breakdown), fluctuating between $0.41 and $0.41, a 0 trading range. While recent weeks have seen some volatility, CLSD has managed to secure a -85.66% drop over the past 2 weeks. The neutral price movement was accompanied by remained steady trading volume, with approximately 2.05M shares changing hands, 0 fewer than the previous session. This amounted to $839.10K in total market activity.
Will CLSD Continue Its Downward Trend?
According to analyst ratings and projections for CLSD, Clearside Biomedical, Inc. shares are anticipated to decrease by -36.39%, potentially reaching $0.30 per share by March 23, 2026. Short-term technical indicators for CLSD currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 19 negative trading days within the past 30 sessions. Based on the CLSD stock forecast, now is not the best time to buy CLSD stock because its current trading price is - our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on CLSD covering social and institutional perspectives.
CLSD Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into CLSD's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 46.77% to 50.65%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 40.74%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 41.07%, maintains a neutral outlook for the long term. Insights into CLSD's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Clearside Biomedical Short-Term Forecasts
CLSD Forecast For Next 5 Days
Our algorithm anticipates Clearside Biomedical (CLSD) stock could hit $0.12 by Mar 27, 2026. This represents a -69.95% fall from today's price, following a -84.29% change over the past five days.
CLSD Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Clearside Biomedical, Inc. (CLSD) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.11, which would mean a -73.17% decrease from the current price of $0.41. Projections for this period range from a high of $0.83 to a low of $0.00.
CLSD Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Clearside Biomedical's price over the next three months point to a rise. CLSD stock is expected to peak at $3.19 on Mar 20, 2026 before potentially dipping to $0.02 on Jun 10, 2026. On average, CLSD is likely to trade around $1.40 in the coming 90 days.
Clearside Biomedical Stock Forecast 2025
Based on our predictive models, Clearside Biomedical (CLSD) is expected to trade between $0.00 and $3.19 throughout 2026. This would result in an average price of $0.68, potentially offering investors a +65.85% return from current levels.
Clearside Biomedical, Inc. Monthly Forecast 2026–2027
March 2026
According to our latest forecast models, Clearside Biomedical, Inc. (CLSD) is positioned to show a strong performance in March 2026. The price is predicted to move between $1.10 and $3.19, settling at an average of $2.16. This could translate to a +426.83% gain.
April 2026
Based on current market signals, Clearside Biomedical, Inc. is projected to trend april 2026. We forecast a trading range from $0.49 to $2.78, with a likely average price of $1.51. Investors could expect a potential return of +268.29%.
May 2026
Our predictive algorithms indicate Clearside Biomedical, Inc. stock may see a shift in May 2026. The expected range spans $0.23–$2.39, with an average target of $1.27. This represents a positive outlook and a possible gain of +209.76%.
June 2026
Analyzing established trends, Clearside Biomedical, Inc. looks set to move in June 2026. Projections place the stock between $0.00 and $1.94, averaging around $0.94. This suggests a +129.27% gain from current levels.
July 2026
Market indicators suggest Clearside Biomedical, Inc. could experience notable changes during July 2026. Prices could fluctuate within $0.00 to $1.59, with a midpoint forecast of $0.62. The stock might deliver a +51.22% gain.
August 2026
Forecasting for August 2026, models estimate that Clearside Biomedical, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $1.41, averaging $0.41. This signals a positive trajectory with potential returns around 0.
September 2026
According to our latest forecast models, Clearside Biomedical, Inc. (CLSD) is positioned to show a strong performance in September 2026. The price is predicted to move between $0.00 and $1.26, settling at an average of $0.28. This could translate to a -31.71% loss.
October 2026
Based on current market signals, Clearside Biomedical, Inc. is projected to trend october 2026. We forecast a trading range from $0.00 to $1.21, with a likely average price of $0.25. Investors could expect a potential return of -39.02%.
November 2026
Our predictive algorithms indicate Clearside Biomedical, Inc. stock may see a shift in November 2026. The expected range spans $0.00–$1.10, with an average target of $0.17. This represents a cautious outlook and a possible loss of -58.54%.
December 2026
Analyzing established trends, Clearside Biomedical, Inc. looks set to move in December 2026. Projections place the stock between $0.00 and $1.04, averaging around $0.13. This suggests a -68.29% loss from current levels.
January 2027
Market indicators suggest Clearside Biomedical, Inc. could experience notable changes during January 2027. Prices could fluctuate within $0.00 to $1.04, with a midpoint forecast of $0.11. The stock might deliver a -73.17% loss.
February 2027
Forecasting for February 2027, models estimate that Clearside Biomedical, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $1.07, averaging $0.08. This signals a cautious trajectory with potential returns around -80.49%.
March 2027
According to our latest forecast models, Clearside Biomedical, Inc. (CLSD) is positioned to show a strong performance in March 2027. The price is predicted to move between $0.00 and $0.95, settling at an average of $0.07. This could translate to a -82.93% loss.
CLSD's history of dividends and stock splits also plays a role in long-term investor confidence.